Home › Leucemia mieloide acuta › Virginia › Richmond
Studi clinici su Leucemia mieloide acuta a Richmond, VA
12 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Richmond e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- e altri 3
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Virginia Commonwealth University - Massey Cancer Center, Richmond
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- VCU Massey Comprehensive Cancer Center, Richmond
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
In reclutamentoFase 2
- Virginia Commonwealth University, Richmond
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- VCU Massey Comprehensive Cancer Center, Richmond
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- VCU Massey Comprehensive Cancer Center, Richmond
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Virginia Commonwealth University, Richmond
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
In reclutamentoFase 4
- Virginia Commonwealth University, Richmond
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
In reclutamentoFase 1
- Virginia Commonwealth University, Richmond
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Richmond
- Cancro al seno26 studi
- Cancro del polmone non a piccole cellule25 studi
- Cancro alla prostata19 studi
- Insufficienza cardiaca16 studi
- Cancro ai polmoni14 studi
- Malattie cardiovascolari13 studi
- Cancro colorettale13 studi
- Malattia epatica steatosica12 studi
- Cancro metastatico12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
- Melanoma11 studi
- Obesità11 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.